Research statistics

Calcitonin Salmon research: publications and trials

What has been published on Calcitonin Salmon: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Calcitonin Salmon works or is safe. For what it is and what the studies found, see the Calcitonin Salmon profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

1,766

Since 1969

Publications in 2026 so far

14

Through November 15, 2026

Human clinical research

31.3%

526 of 1,678 classified

Registered clinical trials

19

ClinicalTrials.gov

Randomized controlled trials

189

Publications reporting an RCT in people

Systematic reviews and meta-analyses

5

Preclinical studies

61.3%

777 animal · 250 in vitro · 2 computational

Records that only mention it

251

Not counted above

Status in the library: FDA-approved. 88 publications are not yet classified by study type.

Publications by year

Calcitonin Salmon publications by year and evidence

1969, Preclinical (animal, in vitro, computational): 2 of 31969, Other and not yet classified: 1 of 31970, Preclinical (animal, in vitro, computational): 2 of 21971, Preclinical (animal, in vitro, computational): 2 of 31971, Other and not yet classified: 1 of 31972, Human clinical research: 2 of 71972, Preclinical (animal, in vitro, computational): 1 of 71972, Other and not yet classified: 4 of 71973, Human clinical research: 2 of 101973, Preclinical (animal, in vitro, computational): 4 of 101973, Other and not yet classified: 4 of 101974, Human clinical research: 2 of 141974, Preclinical (animal, in vitro, computational): 6 of 141974, Other and not yet classified: 6 of 141975, Human clinical research: 8 of 271975, Preclinical (animal, in vitro, computational): 11 of 271975, Reviews and meta-analyses: 1 of 271975, Other and not yet classified: 7 of 271976, Human clinical research: 12 of 251976, Preclinical (animal, in vitro, computational): 10 of 251976, Other and not yet classified: 3 of 251977, Human clinical research: 12 of 301977, Preclinical (animal, in vitro, computational): 14 of 301977, Other and not yet classified: 4 of 301978, Human clinical research: 10 of 171978, Preclinical (animal, in vitro, computational): 5 of 171978, Reviews and meta-analyses: 1 of 171978, Other and not yet classified: 1 of 171979, Human clinical research: 15 of 251979, Preclinical (animal, in vitro, computational): 8 of 251979, Reviews and meta-analyses: 1 of 251979, Other and not yet classified: 1 of 251980, Human clinical research: 6 of 211980, Preclinical (animal, in vitro, computational): 12 of 211980, Reviews and meta-analyses: 1 of 211980, Other and not yet classified: 2 of 211981, Human clinical research: 14 of 281981, Preclinical (animal, in vitro, computational): 11 of 281981, Other and not yet classified: 3 of 281982, Human clinical research: 7 of 291982, Preclinical (animal, in vitro, computational): 18 of 291982, Other and not yet classified: 4 of 291983, Human clinical research: 6 of 351983, Preclinical (animal, in vitro, computational): 24 of 351983, Other and not yet classified: 5 of 351984, Human clinical research: 12 of 431984, Preclinical (animal, in vitro, computational): 27 of 431984, Other and not yet classified: 4 of 431985, Human clinical research: 7 of 451985, Preclinical (animal, in vitro, computational): 32 of 451985, Other and not yet classified: 6 of 451986, Human clinical research: 13 of 451986, Preclinical (animal, in vitro, computational): 27 of 451986, Reviews and meta-analyses: 1 of 451986, Other and not yet classified: 4 of 451987, Human clinical research: 22 of 611987, Preclinical (animal, in vitro, computational): 33 of 611987, Reviews and meta-analyses: 1 of 611987, Other and not yet classified: 5 of 611988, Human clinical research: 24 of 681988, Preclinical (animal, in vitro, computational): 35 of 681988, Reviews and meta-analyses: 2 of 681988, Other and not yet classified: 7 of 681989, Human clinical research: 28 of 581989, Preclinical (animal, in vitro, computational): 25 of 581989, Reviews and meta-analyses: 2 of 581989, Other and not yet classified: 3 of 581990, Human clinical research: 26 of 561990, Preclinical (animal, in vitro, computational): 24 of 561990, Reviews and meta-analyses: 2 of 561990, Other and not yet classified: 4 of 561991, Human clinical research: 28 of 651991, Preclinical (animal, in vitro, computational): 28 of 651991, Reviews and meta-analyses: 8 of 651991, Other and not yet classified: 1 of 651992, Human clinical research: 29 of 591992, Preclinical (animal, in vitro, computational): 23 of 591992, Reviews and meta-analyses: 3 of 591992, Other and not yet classified: 4 of 591993, Human clinical research: 27 of 731993, Preclinical (animal, in vitro, computational): 36 of 731993, Reviews and meta-analyses: 8 of 731993, Other and not yet classified: 2 of 731994, Human clinical research: 18 of 511994, Preclinical (animal, in vitro, computational): 27 of 511994, Reviews and meta-analyses: 2 of 511994, Other and not yet classified: 4 of 511995, Human clinical research: 16 of 671995, Preclinical (animal, in vitro, computational): 43 of 671995, Reviews and meta-analyses: 4 of 671995, Other and not yet classified: 4 of 671996, Human clinical research: 14 of 421996, Preclinical (animal, in vitro, computational): 26 of 421996, Reviews and meta-analyses: 2 of 421997, Human clinical research: 18 of 501997, Preclinical (animal, in vitro, computational): 25 of 501997, Reviews and meta-analyses: 3 of 501997, Other and not yet classified: 4 of 501998, Human clinical research: 10 of 421998, Preclinical (animal, in vitro, computational): 25 of 421998, Reviews and meta-analyses: 5 of 421998, Other and not yet classified: 2 of 421999, Human clinical research: 8 of 421999, Preclinical (animal, in vitro, computational): 30 of 421999, Reviews and meta-analyses: 4 of 422000, Human clinical research: 6 of 322000, Preclinical (animal, in vitro, computational): 23 of 322000, Reviews and meta-analyses: 2 of 322000, Other and not yet classified: 1 of 322001, Human clinical research: 7 of 322001, Preclinical (animal, in vitro, computational): 18 of 322001, Reviews and meta-analyses: 5 of 322001, Other and not yet classified: 2 of 322002, Human clinical research: 8 of 282002, Preclinical (animal, in vitro, computational): 15 of 282002, Reviews and meta-analyses: 4 of 282002, Other and not yet classified: 1 of 282003, Human clinical research: 3 of 342003, Preclinical (animal, in vitro, computational): 30 of 342003, Reviews and meta-analyses: 1 of 342004, Human clinical research: 8 of 372004, Preclinical (animal, in vitro, computational): 27 of 372004, Reviews and meta-analyses: 2 of 372005, Human clinical research: 15 of 342005, Preclinical (animal, in vitro, computational): 18 of 342005, Other and not yet classified: 1 of 342006, Human clinical research: 10 of 302006, Preclinical (animal, in vitro, computational): 19 of 302006, Reviews and meta-analyses: 1 of 302007, Human clinical research: 2 of 232007, Preclinical (animal, in vitro, computational): 18 of 232007, Reviews and meta-analyses: 3 of 232008, Human clinical research: 9 of 232008, Preclinical (animal, in vitro, computational): 11 of 232008, Reviews and meta-analyses: 1 of 232008, Other and not yet classified: 2 of 232009, Human clinical research: 6 of 212009, Preclinical (animal, in vitro, computational): 14 of 212009, Other and not yet classified: 1 of 212010, Human clinical research: 5 of 282010, Preclinical (animal, in vitro, computational): 19 of 282010, Reviews and meta-analyses: 3 of 282010, Other and not yet classified: 1 of 282011, Human clinical research: 6 of 292011, Preclinical (animal, in vitro, computational): 20 of 292011, Reviews and meta-analyses: 2 of 292011, Other and not yet classified: 1 of 292012, Human clinical research: 5 of 282012, Preclinical (animal, in vitro, computational): 22 of 282012, Other and not yet classified: 1 of 282013, Preclinical (animal, in vitro, computational): 17 of 212013, Reviews and meta-analyses: 2 of 212013, Other and not yet classified: 2 of 212014, Human clinical research: 6 of 252014, Preclinical (animal, in vitro, computational): 19 of 252015, Human clinical research: 6 of 212015, Preclinical (animal, in vitro, computational): 13 of 212015, Reviews and meta-analyses: 2 of 212016, Human clinical research: 7 of 202016, Preclinical (animal, in vitro, computational): 12 of 202016, Reviews and meta-analyses: 1 of 202017, Human clinical research: 6 of 202017, Preclinical (animal, in vitro, computational): 13 of 202017, Other and not yet classified: 1 of 202018, Human clinical research: 2 of 132018, Preclinical (animal, in vitro, computational): 10 of 132018, Reviews and meta-analyses: 1 of 132019, Human clinical research: 1 of 172019, Preclinical (animal, in vitro, computational): 16 of 172020, Human clinical research: 1 of 292020, Preclinical (animal, in vitro, computational): 23 of 292020, Reviews and meta-analyses: 5 of 292021, Human clinical research: 4 of 172021, Preclinical (animal, in vitro, computational): 10 of 172021, Reviews and meta-analyses: 3 of 172022, Human clinical research: 2 of 112022, Preclinical (animal, in vitro, computational): 9 of 112023, Preclinical (animal, in vitro, computational): 8 of 92023, Reviews and meta-analyses: 1 of 92024, Human clinical research: 1 of 152024, Preclinical (animal, in vitro, computational): 11 of 152024, Reviews and meta-analyses: 2 of 152024, Other and not yet classified: 1 of 152025, Preclinical (animal, in vitro, computational): 12 of 122026 (to date), Human clinical research: 4 of 142026 (to date), Preclinical (animal, in vitro, computational): 6 of 142026 (to date), Reviews and meta-analyses: 3 of 142026 (to date), Other and not yet classified: 1 of 14Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified020406080196919811993200520172026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
196902013
197002002
197102013
197221047
1973240410
1974260614
19758111727
197612100325
197712140430
19781051117
19791581125
19806121221
198114110328
19827180429
19836240535
198412270443
19857320645
198613271445
198722331561
198824352768
198928252358
199026242456
199128288165
199229233459
199327368273
199418272451
199516434467
199614262042
199718253450
199810255242
19998304042
20006232132
20017185232
20028154128
20033301034
20048272037
200515180134
200610191030
20072183023
20089111223
20096140121
20105193128
20116202129
20125220128
20130172221
20146190025
20156132021
20167121020
20176130120
20182101013
20191160017
20201235029
20214103017
2022290011
202308109
20241112115
20250120012
2026 (to date)463114

Study types

Animal study777
In vitro study250
Other clinical trial217
Randomized controlled trial189
Review90
Not yet classified88
Case report80
Observational human study40
Editorial, letter or other28
Meta-analysis5
Computational study2

Research areas

From MeSH major topics. A paper can be in several areas.

Musculoskeletal709
Metabolic health522
Endocrinology430
Neurological and mental health222
Oncology113
Gastrointestinal102
Tissue repair88
Reproductive and sexual health64
Immune system58
Cardiovascular41
Obesity and weight management29
Dermatology28

Registered clinical trials

0 of 8 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 15 · Terminated: 2 · Recruiting: 1 · Withdrawn: 1
Phase not applicable: 1 · Phase 1: 4 · Phase 2: 3 · Phase 3: 6 · Phase 4: 5

TrialStatusPhaseStartedResults
The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring InjuriesNCT03812991 · 21 enrolledCompletedPhase 42019-07Posted
Calcitonin Pre-treatment to Improve SPECT-CT SensitivityNCT03935984 · 37 enrolledRecruitingPhase 42019-05—
Hypothyroidism Treated With CalcitoninNCT03342001 · 11 enrolledCompletedPhase 42018-06Posted
Calcitonin for Treating X-linked HypophosphatemiaNCT01652573 · 21 enrolledCompletedPhase not applicable2011-03Posted
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic WomenNCT00959764 · 565 enrolledCompletedPhase 32009-06Posted
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal WomenNCT00803686 · 12 enrolledCompletedPhase 22008-12Posted
Calcitonin in the Treatment of FibromyalgiaNCT00754884WithdrawnPhase 42008-10—
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)NCT00704847 · 1,030 enrolledTerminatedPhase 32008-06Posted
A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal WomenNCT00620854 · 24 enrolledCompletedPhase 22008-02Posted
Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal WomenNCT00372099 · 90 enrolledCompletedPhase 32007-01—
SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days StudyNCT00486369CompletedPhase 12007-01—
A Study for Patients With OsteoporosisNCT00414973 · 364 enrolledCompletedPhase 32006-12Posted
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal WomenNCT00395395 · 56 enrolledCompletedPhase 12006-10—
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal WomenNCT00411125 · 86 enrolledCompletedPhase 12006-08—
Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With OsteoarthritisNCT00486317CompletedPhase 12005-10—
Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisNCT00542984 · 70 enrolledCompletedPhase 32003-08—
A Study of the Treatment of Postmenopausal Women With OsteoporosisNCT00543023 · 104 enrolledCompletedPhase 32003-06—
Effects of Oral Salmon Calcitonin in Human OsteoarthritisNCT00376311 · 54 enrolledTerminatedPhase 22002-09—
Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenNCT00239889 · 300 enrolledCompletedPhase 42002-03—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. A meta-analysis of the therapeutic effect of intranasal salmon calcitonin on osteoporosis.

    European journal of medical research · December 8, 2021 · Meta-analysis · cited 22 times · open access

    PMID 34879875 · DOI 10.1186/s40001-021-00610-x · Reviews and meta-analyses

  2. Effects of Teriparatide versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials.

    Endocrine, metabolic & immune disorders drug targets · January 1, 2021 · Meta-analysis · cited 8 times

    PMID 33109070 · DOI 10.2174/1871530320999200817114817 · Reviews and meta-analyses

  3. Efficacy of calcitonin for treating acute pain associated with osteoporotic vertebral compression fracture: an updated systematic review.

    CJEM · May 1, 2020 · Meta-analysis · cited 31 times · open access

    PMID 32188529 · DOI 10.1017/cem.2019.490 · Reviews and meta-analyses

  4. Does salmon calcitonin cause cancer? A review and meta-analysis.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · October 5, 2015 · Meta-analysis · cited 71 times · open access

    PMID 26438308 · DOI 10.1007/s00198-015-3339-z · Reviews and meta-analyses

  5. Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation.

    PharmacoEconomics · January 1, 2001 · Meta-analysis · cited 41 times

    PMID 11465301 · DOI 10.2165/00019053-200119050-00010 · Reviews and meta-analyses

  6. The Effect of Salmon Calcitonin Adjuvant Treatment for Lumbar Spine Fracture: A Prospective, Randomized, Controlled Trial.

    Journal of nutritional science and vitaminology · January 1, 2024 · Randomized controlled trial · cited 1 times · open access

    PMID 39477477 · DOI 10.3177/jnsv.70.406 · Human clinical research

  7. Evaluation of the efficacy of salmon calcitonin nasal spray on bone healing following open reduction and internal fixation of mandibular fractures - A randomized controlled trial.

    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · August 30, 2021 · Randomized controlled trial · cited 14 times

    PMID 34593298 · DOI 10.1016/j.jcms.2021.08.002 · Human clinical research

  8. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.

    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · March 9, 2021 · Randomized controlled trial · cited 45 times · open access

    PMID 33687578 · DOI 10.1186/s10195-021-00572-0 · Human clinical research

  9. A Randomized Placebo-Controlled Trial Evaluating the Analgesic Effect of Salmon Calcitonin in Refractory Bone Metastasis Pain.

    Indian journal of palliative care · January 28, 2020 · Randomized controlled trial · cited 7 times · open access

    PMID 32132775 · DOI 10.4103/ijpc.ijpc_167_19 · Human clinical research

  10. Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia.

    Calcified tissue international · January 30, 2018 · Randomized controlled trial · cited 14 times · open access

    PMID 29383408 · DOI 10.1007/s00223-017-0382-0 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

    The American journal of medicine · September 1, 2000 · Randomized controlled trial · cited 1,125 times

    PMID 10996576 · DOI 10.1016/s0002-9343(00)00490-3 · Human clinical research

  2. Osteoblastic cells are involved in osteoclast formation.

    Endocrinology · November 1, 1988 · Animal study · cited 933 times

    PMID 2844518 · DOI 10.1210/endo-123-5-2600 · Animal studies

  3. Prevention and treatment of postmenopausal osteoporosis.

    The Journal of steroid biochemistry and molecular biology · October 29, 2013 · Review · cited 786 times · open access

    PMID 24176761 · DOI 10.1016/j.jsbmb.2013.09.008 · Reviews and meta-analyses

  4. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

    Endocrinology · April 1, 1988 · Animal study · cited 730 times

    PMID 3345718 · DOI 10.1210/endo-122-4-1373 · Animal studies

  5. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

    The New England journal of medicine · June 1, 1993 · Randomized controlled trial · cited 520 times

    PMID 7684512 · DOI 10.1056/nejm199306173282404 · Human clinical research

Latest publications

  1. Salmon calcitonin prescribing for acute phantom limb pain after amputation.

    Anaesthesia · October 22, 2026 · Not yet classified · cited 0 times · open access

    PMID 42919113 · DOI 10.1111/anae.70444 · Not yet classified

  2. Amylin Receptor Signalling in the Laterodorsal Tegmental Nucleus Controls Food Intake Through Projections to the Ventral Tegmental Area.

    Diabetes, obesity & metabolism · October 6, 2026 · Animal study · cited 0 times · open access

    PMID 42834866 · DOI 10.1111/dom.71415 · Animal studies

  3. Engineering small peptide secretion in <i>Komagataella phaffii</i>.

    Frontiers in bioengineering and biotechnology · September 16, 2026 · In vitro study · cited 0 times · open access

    PMID 42819341 · DOI 10.3389/fbioe.2026.1929744 · In vitro studies

  4. Transient Osteoporosis of Bilateral Knee Joints in Twin Pregnancy: A Case Report - A Valuable Addition to the Medical Literature.

    Journal of orthopaedic case reports · August 1, 2026 · Case report · cited 0 times · open access

    PMID 42598249 · DOI 10.13107/jocr.2026.v16.i08.7850 · Human clinical research

  5. On-demand peptide therapeutics for multi-year space exploration: analysis of clinical and operational relevance and recombinant production feasibility.

    NPJ microgravity · July 9, 2026 · Review · cited 0 times · open access

    PMID 42420311 · DOI 10.1038/s41526-026-00630-z · Reviews and meta-analyses

  6. Impact of hydrophobic ion pair type and self-nanoemulsifying drug delivery systems composition on the oral delivery of salmon calcitonin.

    Journal of controlled release : official journal of the Controlled Release Society · June 25, 2026 · Animal study · cited 0 times · open access

    PMID 42349799 · DOI 10.1016/j.jconrel.2026.115131 · Animal studies

  7. Therapeutic subtypes of knee osteoarthritis: differential treatment effects among predicted endotypes in past clinical trials.

    Arthritis research & therapy · May 7, 2026 · Observational human study · cited 2 times · open access

    PMID 42092979 · DOI 10.1186/s13075-026-03825-7 · Human clinical research

  8. A thermosensitive hydrogel achieves sustained co-delivery of two therapeutic agents with distinct properties for preventing aseptic loosening.

    Biomaterials science · April 21, 2026 · Animal study · cited 1 times · open access

    PMID 41810563 · DOI 10.1039/d6bm00096g · Animal studies

  9. Revisiting Intranasal Salmon Calcitonin: Historical Osteoporosis Evidence and a Potential Role in Acute Orthopaedic Pain Management.

    JBJS reviews · April 7, 2026 · Review · cited 0 times · open access

    PMID 41945663 · DOI 10.2106/jbjs.rvw.26.00021 · Reviews and meta-analyses

  10. Evaluation of the efficacy of salmon calcitonin nasal spray on bone healing following surgical removal of impacted third molar: a randomized controlled study.

    Journal of the Korean Association of Oral and Maxillofacial Surgeons · April 1, 2026 · Review · cited 0 times · open access

    PMID 42055778 · DOI 10.5125/jkaoms.2026.52.2.73 · Reviews and meta-analyses

Browse all 1,766 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Calcitonin Salmon; Fortical; Miacalcin; Ostora; Salcatonin; Salmon calcitonin

((TITLE_ABS:"Calcitonin Salmon" OR CHEM:"Calcitonin Salmon") OR (TITLE_ABS:"Fortical" OR CHEM:"Fortical") OR (TITLE_ABS:"Miacalcin" OR CHEM:"Miacalcin") OR (TITLE_ABS:"Ostora" OR CHEM:"Ostora") OR (TITLE_ABS:"Salcatonin" OR CHEM:"Salcatonin") OR (TITLE_ABS:"Salmon calcitonin" OR CHEM:"Salmon calcitonin")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Calcitonin Salmon research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/calcitonin-salmon